PTPN1 splice variants could up-regulated JAK/STAT activity in classic Hodgkin lymphoma cells, accelerated tumor cell proliferation, and reduced the toxicity effect of chemotherapy drugs such as gessabine and oroposide (34, 35). This evidence concerns the gene PTPN1 and Hodgkins lymphoma.